Jefferies analyst Eun Yang reiterated a Buy rating and $11.50 price target on Opko Health (NYSE: OPK) following the company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE